Become an Ottawa Business Journal Insider and get immediate access to all of our Insider-only content and much more. Learn More and Become an Insider Critical Ottawa business news and analysis updated ...

CHARLOTTE — Residents in west Charlotte said they support plans to transform a former library into a community center and county commissioners want to team up with a nonprofit to step up a one-stop ...

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent. Loading security verification... Get this delivered to your ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

NEW YORK and HONG KONG, Oct. 14, 2025 /PRNewswire/ -- Cisdem has released a significant update to its popular Video Converter, introducing AI-powered video upscaling and intelligent noise reduction.

Popular YouTuber MrBeast is reportedly eyeing a move into crypto entrepreneurship. James "Jimmy" Donaldson, known as MrBeast, is the world's most popular YouTuber with over 445 million subscribers. He ...

Soldiers load into an Infantry Squad Vehicle during a live fire exercise in Grafenwoehr Training Area, Germany. (Kevin Sterling Payne/U.S. Army) Over the next two years, the U.S. Army will convert 25 ...

With 446 million followers on his main YouTube channel alone, Donaldson is the world’s most subscribed YouTuber of all time. Since Donaldson first began posting videos in 2011, he’s gone from a ...

Georgia congresswoman Marjorie Taylor Greene says House Speaker Mike Johnson needs to get the government back to work to secure the release of the Epstein files. While Greene has been one of Donald ...

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...